An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Anti-TNF Therapy (REPEAT)

NCT01196780 · clinicaltrials.gov ↗
TERMINATED
Status
1240
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

Hoffmann-La Roche